SCI Abstract

search
Prognostic revalidation of RANO categories for extent of resection in glioblastoma: a reconstruction of individual patient data
Prognostic revalidation of RANO categories for extent of resection in glioblastoma: a reconstruction of individual patient data
The RANO classification for glioblastoma defines resection categories based on volumetric tumor assessments, aiming to sta...
Establishment and transcriptomic characteristics of radio-resistant meningioma cell lines
Establishment and transcriptomic characteristics of radio-resistant meningioma cell lines
Radio-resistance poses a significant challenge in meningioma treatment. This study aimed to establish radio-resistant meni...
Improving IL12 immunotherapy in glioblastoma by targeting the long noncoding RNA
Improving IL12 immunotherapy in glioblastoma by targeting the long noncoding RNA
The potent antitumor effects of interleukin 12 (IL12) gene therapy in glioblastoma (GBM) are significantly attenuated by t...
Current clinical trials for craniopharyngiomas: what’s on the horizon?
Current clinical trials for craniopharyngiomas: what’s on the horizon?
Craniopharyngiomas are histologically low-grade tumors in the sellar/suprasellar region that grow close to critical struct...
Extra-central nervous system metastasis from high-grade glioma: a single-institution experience
Extra-central nervous system metastasis from high-grade glioma: a single-institution experience
Extra-central nervous system metastasis (ECM) from glioblastoma and other high-grade gliomas (HGGs) is exceedingly rare, l...
Characterizing the molecular and spatial heterogeneity of midline gliomas in adults: a single institution analysis
Characterizing the molecular and spatial heterogeneity of midline gliomas in adults: a single institution analysis
Primary gliomas arising within midline structures of the central nervous system are associated with a worse prognosis comp...
Gene therapy and genome-editing for schwannoma in -related schwannomatosis: current understanding and future directions
Gene therapy and genome-editing for schwannoma in -related schwannomatosis: current understanding and future directions
NF2-related schwannomatosis (NF2-SWN) is a rare genetic disorder characterized by bilateral vestibular schwannomas. NF2-SW...
Clinical trial design for novel targeted agents in neuro-oncology
Clinical trial design for novel targeted agents in neuro-oncology
Biomarker-based clinical trials investigating targeted treatments for brain tumors have surged due to better access to bio...
In-patient neurosurgical tumor treatments for malignant glioma patients in Germany
In-patient neurosurgical tumor treatments for malignant glioma patients in Germany
Treatment for malignant gliomas involves multiple disciplines, including neurosurgery, radiation therapy, medical and neur...
Social media “SoMe” in neuro-oncology: a review of the literature
Social media “SoMe” in neuro-oncology: a review of the literature
This article examines the current state of social media (SoMe) in neuro-oncology and neurosurgical oncology. The goal of t...
Quality of life after stereotactic radiosurgery for brain metastasis: an assessment from a prospective national registry
Quality of life after stereotactic radiosurgery for brain metastasis: an assessment from a prospective national registry
Stereotactic radiosurgery (SRS) is frequently used in the management of brain metastasis patients. However, there is an ur...
A multi-center, clinical analysis of IDH-mutant gliomas, WHO Grade 4: implications for prognosis and clinical trial design
A multi-center, clinical analysis of IDH-mutant gliomas, WHO Grade 4: implications for prognosis and clinical trial design
Mutations in the Isocitrate Dehydrogenase (IDH) genes, IDH1 or IDH2, define a group of adult diffuse gliomas associated wi...
Targeting the RAS/MAPK pathway in children with glioma
Targeting the RAS/MAPK pathway in children with glioma
Pediatric gliomas are the most common brain tumor in children, encompassing both low-grade glioma (pLGG) and high-grade gl...